RefBan

Referral Banners

Yashi

Friday, April 25, 2014

Reuters Health Report

Click to View in Browser
04/25/2014
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Experts cast doubt on Saudi push for Middle East virus vaccine
LONDON (Reuters) - Official talk in Saudi Arabia of racing to develop a vaccine against a deadly new virus may be a way to reassure a fearful population, but it is scientifically wide of the mark and makes little sense in public health terms.
Novartis lung drug not inferior to GSK's Seretide, study shows
ZURICH (Reuters) - Patients taking Novartis' inhaled medicine Onbrez Breezhaler for chronic lung disease had benefits similar to those taking GlaxoSmithKline's Seretide, the Swiss drugmaker said on Friday, citing a late stage study.
U.S. proposal would ban e-cigarette sales to minors, allow advertising
WASHINGTON (Reuters) - The U.S. Food and Drug Administration proposed rules on Thursday that would ban the sale of e-cigarettes to anyone under 18, but would not restrict flavored products, online sales or advertising, which public health advocates say attract children.
Oregon's broken healthcare exchange may move to federal network
PORTLAND (Reuters) - Top officials for Oregon's troubled health insurance network, dogged by technical glitches that have kept a single subscriber from enrolling online, recommended on Thursday dumping the state website in favor of a federally run healthcare exchange.
Behavior therapy works over short term for young kids with OCD
NEW YORK (Reuters Health) - A family-based cognitive behavioral therapy markedly improves symptoms in children as young as five years old with obsessive-compulsive disorder (OCD), according to a new study.
Exclusive: Allergan approached Shire about takeover but rebuffed -sources
NEW YORK (Reuters) - Allergan Inc approached Shire Plc in recent months about a possible takeover but was rebuffed, according to people familiar with the matter, in the latest example of a U.S. drugmaker seeking to buy an overseas rival to lower its tax rate.
Utah sperm swap 'unacceptable' but still unexplained -university docs
(Reuters) - A University of Utah committee investigating reports that a Salt Lake City fertility clinic worker artificially inseminated a patient with his own sperm called the action "unacceptable" on Thursday, but said it could not determine whether the switch was intentional.
Caregivers Are Key In Protecting Kids' Dental Health
NEW YORK (Reuters Health) - Many kids on Medicaid are not receiving dental care, and those who do often first show up with a dental emergency, according to a new study.
Webby Awards honor mobile health and fitness apps
NEW YORK (Reuters Health) - As part of the 18th Annual Webby Awards, 11 mobile health applications ranging from personal wellness journals to allergen and symptom trackers were chosen as honorees.
Vaccines prevent more than 700,000 child deaths in the U.S.: CDC
ATLANTA (Reuters) - A federal government program launched 20 years ago to increase vaccinations for low-income children in the United States will prevent more than 700,000 deaths, but measles remains a stubborn adversary, with more than 129 cases so far this year, a federal agency said on Thursday.
Related Video
One million endangered orchids to be planted in South Florida
Buffett: Investing in wind projects high on priority list
SUBSCRIBE TO OTHER REUTERS NEWSLETTERS
 Reuters Deals Today
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
Reuters Business Today
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
» MORE NEWSLETTERS
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments:

Yashi

Chitika